Concepedia

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

C. Michael Gibson, Roxana Mehran, Christoph Bode, J. Halperin, Freek W.A. Verheugt, Peter Wildgoose, Martin van Eickels, Gregory Y.H. Lip, Marc Cohen, Steen Husted,

American Heart Journal · 2014 · 171 citations · 16 references

References

16

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Philip A. Wolf, Robert D. Abbott, W B Kannel · Stroke · 1991 · 7.5K citations

Medicine, Cardiology, Clinical Cardiology +14

Prevalence of Diagnosed Atrial Fibrillation in Adults

Alan S. Go, Elaine M. Hylek, Kathleen A. Phillips et al. · JAMA · 2001 · 6.2K citations

Medicine, Cardiology, Internal Medicine +16

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · European Heart Journal · 2010 · 5.9K citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

The Lancet · 2006 · 2K citations

Medicine, Cardiology, Pharmacology +11